{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:14:52Z","timestamp":1788441292820,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019778","name":"US President's Malaria Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lanmic.2025.101342","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:37:32Z","timestamp":1780947452000},"page":"101342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of chloroquine plus low-dose primaquine and pyronaridine\u2013artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2\/3, observer-masked, randomised, parallel-group trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Migbaru Keffale","family":"Bezabih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Sisay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinknesh Wolde","family":"Behaksera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-7395","authenticated-orcid":false,"given":"Jordache","family":"Ramjith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6753-7819","authenticated-orcid":false,"given":"Hiwot","family":"Teka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanuel","family":"Shimelash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Legesse Alamerie","family":"Ejigu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikregabrail Aberra","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bereket","family":"Hailegiorgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekonnen","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7994-3797","authenticated-orcid":false,"given":"Tadesse","family":"Misganaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addisu","family":"Gizat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrham","family":"Gashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getinet","family":"Habtamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negash Seyoum","family":"Legesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natnael Lemessa","family":"Hundera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Woldesenbet","family":"Milki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melat","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakweya","family":"Chali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Eric","family":"Tongren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-2664","authenticated-orcid":false,"given":"Jimee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun","family":"Bousema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1931-1442","authenticated-orcid":false,"given":"Fitsum G","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lanmic.2025.101342_bib2","article-title":"Disease outbreak news: Malaria\u2013Ethiopia","volume":"11","year":"2024","journal-title":"Malaria World News (31 October 2024)"},{"key":"10.1016\/j.lanmic.2025.101342_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009781","article-title":"Plasmodium vivax epidemiology in Ethiopia 2000\u20132020: a systematic review and meta-analysis","volume":"15","author":"Ketema","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2025.101342_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40794-022-00185-3","article-title":"Plasmodium vivax: the potential obstacles it presents to malaria elimination and eradication","volume":"8","author":"Habtamu","year":"2022","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.lanmic.2025.101342_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","article-title":"Plasmodium vivax in the era of the shrinking P falciparum map","volume":"36","author":"Price","year":"2020","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.lanmic.2025.101342_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(10)70079-7","article-title":"Artemisinin combination therapy for vivax malaria","volume":"10","author":"Douglas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101342_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014501","article-title":"Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial","volume":"6","author":"Poravuth","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101342_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12936-022-04422-0","article-title":"Efficacy and safety of pyronaridine\u2013artesunate (Pyramax\u00ae) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia","volume":"21","author":"Mohammed","year":"2022","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101342_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004683","article-title":"The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: a pooled analysis of individual participant data","volume":"22","author":"Vanheer","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanmic.2025.101342_bib13","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3201\/eid2408.170768","article-title":"Therapeutic and transmission-blocking efficacy of dihydroartemisinin\/piperaquine and chloroquine against Plasmodium vivax malaria, Cambodia","volume":"24","author":"Popovici","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101342_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00853-24","article-title":"Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes","volume":"68","author":"Chaumeau","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2025.101342_bib15","article-title":"Evaluation of the efficacy of artemether\u2013lumefantrine and artesunate\u2013pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2\/3, observer-masked, randomised, parallel-group trial","volume":"7","author":"Bezabih","year":"2026","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2025.101342_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13071-020-3998-2","article-title":"Comparison of infectivity of Plasmodium vivax to wild-caught and laboratory-adapted (colonized) Anopheles arabiensis mosquitoes in Ethiopia","volume":"13","author":"Chali","year":"2020","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.lanmic.2025.101342_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076316","article-title":"Strategies for detection of plasmodium species gametocytes","volume":"8","author":"Wampfler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101342_bib19","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S2352-3026(18)30004-8","article-title":"Revisiting WHO haemoglobin thresholds to define anaemia in clinical medicine and public health","volume":"5","author":"Pasricha","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.lanmic.2025.101342_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899615","article-title":"Quantifying reductions in Plasmodium falciparum infectivity to mosquitos: a sample size calculator to inform clinical trials on transmission-reducing interventions","volume":"13","author":"Ramjith","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanmic.2025.101342_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107010","article-title":"Dynamics of asymptomatic Plasmodium falciparum and Plasmodium vivax infections and their infectiousness to mosquitoes in a low transmission setting of Ethiopia: a longitudinal observational study","volume":"143","author":"Hailemeskel","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101342_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12936-015-1041-4","article-title":"Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia","volume":"14","author":"Getachew","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101342_bib23","article-title":"In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia","volume":"8","author":"Hwang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101342_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277362","article-title":"Therapeutic efficacy of chloroquine for the treatment of uncomplicated Plasmodium vivax infection in Shewa Robit, Northeast Ethiopia","volume":"18","author":"Belay","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101342_bib25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12936-024-05124-5","article-title":"In vivo efficacy of chloroquine plus primaquine combination therapy against uncomplicated Plasmodium vivax malaria in Limu Kossa District, Jimma Zone, Southwest Ethiopia","volume":"23","author":"Asfaw","year":"2024","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101342_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12936-023-04562-x","article-title":"Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response","volume":"22","author":"Mekonnen","year":"2023","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101342_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpddr.2019.09.002","article-title":"Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia","volume":"11","author":"Hailemeskel","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.lanmic.2025.101342_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00628-22","article-title":"Infectivity of symptomatic patients and their contribution for infectiousness of mosquitoes following a membrane feeding assay in Ethiopia","volume":"10","author":"Abate","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.lanmic.2025.101342_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011425","article-title":"Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi","volume":"17","author":"Andrade","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2025.101342_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02108-19","article-title":"Significant efficacy of a single low dose of primaquine compared to stand-alone artemisinin combination therapy in reducing gametocyte carriage in Cambodian patients with uncomplicated multidrug-resistant Plasmodium falciparum malaria","volume":"64","author":"Vantaux","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2025.101342_bib31","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/cid\/ciz134","article-title":"Transmission-blocking effects of primaquine and methylene blue suggest Plasmodium falciparum gametocyte sterilization rather than effects on sex ratio","volume":"69","author":"Bradley","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101342_bib32","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/S2666-5247(21)00192-0","article-title":"Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouelessebougou, Mali: a four-arm, single-blind, phase 2\/3, randomised trial","volume":"3","author":"Stone","year":"2022","journal-title":"Lancet Microbe"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725002708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725002708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:25:00Z","timestamp":1788438300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524725002708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666524725002708"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101342","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of chloroquine plus low-dose primaquine and pyronaridine\u2013artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2\/3, observer-masked, randomised, parallel-group trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101342"}}